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Two-year follow-up of a randomized controlled trial of a clinical nurse specialist
intervention, inpatient, and day patient team care in rheumatoid arthritis
Aim. To compare the long-term effectiveness of care delivered by a clinical nurse
specialist (CNS) with inpatient team care and day patient team care in patients with
rheumatoid arthritis and increasing functional limitations.
Background. The role of CNSs in the management of patients with rheumatoid
arthritis (RA) is evolving, and their effectiveness in comparison with care provided
by a rheumatologist alone has been established. However, long-term controlled
studies showing how the effectiveness of CNSs compares with that of other forms of
co-ordinated care, such as multidisciplinary team care, are lacking.
Methods. Two hundred and ten patients rheumatoid arthritis patients were rand-
omized to care delivered by a CNS in a rheumatology outpatient clinic (12 weeks),
inpatient team care (2 weeks) and day patient team care (3 weeks). Clinical
assessments recorded on study entry, weeks 12, 26, 52, 78 and 104 comprised the
health assessment questionnaire (HAQ) and MacMaster Toronto Arthritis
(MACTAR) patient preference interview as primary outcome measures. Grip
strength, walk test, RAND-36, Rheumatoid Arthritis Quality of Life ques-
tionnaire and disease activity score (DAS) were applied as secondary outcome
measures.
Results. No significant differences in medical treatment, use of services of other
health professionals, introduction of adaptive equipment or number of hospitali-
zations were observed between the three treatment groups during 2 year follow-up,
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except that visits to nurse specialists were more frequent and home help was less
frequent in the CNS group. A comparison of clinical outcomes among the three
groups and a comparison between the nurse specialist and inpatient and day patient
care groups together did not show any significant differences. Within all three
groups functional status, quality of life and disease activity improved significantly
(P < 0Æ05). In general, the results obtained after 12 weeks remained stable until
104 weeks after the start of the study.
Conclusion. Care provided by a CNS in an outpatient rheumatology clinic has a
similar long-term clinical outcome to inpatient and day patient team care in patients
with rheumatoid arthritis. A CNS intervention appears to be an effective innovation
in the care for patients with rheumatoid arthritis.
Keywords: rheumatoid arthritis, chronic conditions, clinical nurse specialist,
advanced nursing, nurse clinics, multidisciplinary team care, inpatient, day patient,
randomized trial
Introduction
Rheumatoid arthritis (RA) is a chronic disease which may run
a highly variable course, with periods of flares and remissions
and steadily increasing damage to the joints. Despite new
developments in the medical and surgical treatment, the
disease has major physical, psychological, social and econo-
mic consequences in the majority of patients. Therefore,
patients with RA often need long-term care from a wide
variety of health care professionals and services. Research on
health care utilization by patients with rheumatic diseases has
revealed that they have a relatively high use of health care
services in comparison with patients with other chronic
conditions (Van den Bos 1995, Verbrugge & Patrick 1995).
In a recent Dutch study with 725 patients with RA (Jacobi
et al. 2001) it was demonstrated that within the preceding
12 months 97% of the patients visited a rheumatologist,
42% a general practitioner, 23% an orthopaedic surgeon,
16% a rehabilitation specialist, 10% a plastic surgeon, 9% a
neurologist, and 30% other specialists for RA purposes.
Regarding allied health care, 40% of the patients made use of
physiotherapy, 17% of occupational therapy, and 15% of
chiropody. Furthermore, 18% had home help, and 4%
nursing care at home. A social worker was visited by 10% of
the patients, and 6% visited a psychologist or psychiatrist.
In case of progressive disability as a consequence of
increasing disease activity, joint destruction, the occurrence
of complications or comorbidity, complex interventions
involving various health professionals at the same time are
needed. Co-ordinated care by a team of health professionals
in an inpatient or outpatient setting has long been considered
an optimal form of health care in this situation (Davis et al.
2000). It is known from several randomized trials that
inpatient multidisciplinary team care has a beneficial effect in
patients with active RA in comparison with regular outpa-
tient care, whereas the evidence for effectiveness of outpatient
multidisciplinary team care in comparison with regular
What is already known on this topic
• The role of clinical nurse specialists in the management
of patients with rheumatoid arthritis is evolving.
• The tasks of clinical nurse specialists may vary among
institutions, ranging from substitution to addition of
care provided by the rheumatologist.
• There has been a lack of long-term controlled studies
which compare the effectiveness of clinical nurse spe-
cialists with the care provided by a multidisciplinary
team, that being the treatment strategy that is consid-
ered to be optimal in complex chronic disease man-
agement.
What this study adds
• This randomized study showed that in patients with
rheumatoid arthritis and functional deterioration over a
period of two years, no sustained differences in clinical
effectiveness were identified between care provided by a
clinical nurse specialist in collaboration with a rheu-
matologist and that provided through inpatient or day-
patient team care.
• The results of this study underscore that care provided
by a clinical nurse specialist is a useful alternative to
other available multidisciplinary management strategies
for patients with rheumatoid arthritis in need of com-
plex care.
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outpatient care is conflicting (Vliet Vlieland & Hazes 1997).
With respect to comparisons of different forms of team care
programmes, Helewa et al. (1989) showed that inpatient
team care appeared to be more effective than outpatient team
care. Lambert et al. (1998) showed that the clinical outcome
of team care provided in a day care setting proved to be
equivalent to that of inpatient team care. Both studies
included an economic analysis, showing that inpatient team
care was more expensive than either outpatient or day patient
team care.
Over recent years, limitations in the organization and
availability of these services for large numbers of patients,
and constraints on health care expenditures have created the
need for new forms of complex health care. Over the last
decade, clinical nurse specialists (CNSs) were introduced in
many rheumatology practices, and they provide education,
guidance and clinical care, and enhance and support care
given by other health professionals as well (Bird et al. 1985).
Despite the wide adoption of CNSs in chronic disease
management, evidence for their effectiveness is limited
(Hobbs & Murray 1999). Until 2001, only two studies with
a controlled design had been conducted in the rheumatology
setting (Hill et al. 1994, Hill 1997, Temmink et al. 2001).
The content and organization of care provided by CNSs as
described in these studies varied. In the study from the United
Kingdom (UK) there was substitution of the rheumatologist’s
care by the rheumatology nurse specialist in a hospital setting
(Hill et al. 1994, Hill 1997). In contrast, in the Dutch study
the care provided by the CNS was given in addition to the
usual care provided by the rheumatologist and other health
professionals, under the joint responsibility of a hospital and
home care organization (Temmink et al. 2001). In the study
by Hill et al. it was shown that RA patients, reflecting a
typical cross-section of the rheumatology outpatient popula-
tion, who had had access to a CNS had significantly
improved after 48 weeks with respect to pain, morning
stiffness, psychological status, knowledge and satisfaction
when compared with a group who received usual care
provided by a consultant rheumatologist. In the Netherlands
study, care provided by a CNS in addition to usual care
provided by a rheumatologist did not influence patients’ need
for information, application of practical aids and adapta-
tions, or functional capacity after 26 weeks in comparison
with usual care provided by a rheumatologist. Neither of
these studies included an economic analysis.
A direct comparison of the effectiveness of nurse specialist
care with other forms of intensive, co-ordinated care in
patients in need of complex care has only recently been
carried out by our own group (Tijhuis et al. 2002). It was
shown that care provided by a CNS was in the short term
equally as effective as inpatient and day patient multidisci-
plinary team care However, the long-term outcome of CNS
care remains to be established.
The study
Aim
The present follow-up study was undertaken to evaluate
whether the similar improvement achieved by a short period
of treatment by a CNS in comparison with inpatient team
care and day patient team care could be maintained over a
2-year period.
Methods
Sample and ethical issues
Between December 1996 and January 1999 patients were
recruited in the outpatient clinic of the Rheumatology
Department of six hospitals. The inclusion criteria were RA
as defined by the 1987 American Rheumatism Association
criteria (Arnett et al. 1988) and increasing difficulty in
performing activities of daily living over the last 6 weeks.
Exclusion criteria were medical complications of RA requi-
ring immediate hospitalization and inability to reach the
hospital before 10 a.m. Random allocation was achieved by
randomly assorted cards in sealed envelopes stratified by sex
and centre. Ethical approval had been obtained for the study
in all six participating hospitals. All patients gave written
informed consent. To maintain allocation concealment,
patients were asked not to inform blinded assessors about the
type of care they received.
Patient management protocols
All patients randomized to care provided by a CNS were seen
by a nurse specialist attached to the transmural nurse clinics of
one of the six participating hospitals within 2 weeks after
randomization. Transmural nurse clinics function under the
joint responsibility of both the hospital and primary care
organizations. The care provided by the CNSs was additional
to the usual outpatient care provided by rheumatologists. The
CNSs provided information about RA and prescribed, in
consultation with the rheumatologist, joint splints, adaptive
equipment and house adaptations if needed. If indicated, the
patient could also be referred to other health professionals
such as an occupational therapist, physical therapist or social
worker. The time of termination of care by the CNS was left to
their decision. The mean duration of care by the six CNSs-
was 12 weeks at the time the study was conducted and com-
prised on average three visits to the transmural nurse clinic.
G.J. Tijhuis et al.
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Multidisciplinary inpatient team care and day patient team
care also started within 2 weeks after randomization and
both were given at the rheumatology clinic of the Leiden
University Medical Centre, a referral centre with inpatient
and day care facilities. The multidisciplinary team in both the
inpatient care and day care setting comprised nurses, a
rheumatologist, an occupational therapist, a physical therap-
ist and a social worker. Inpatients and day patients followed
a prescribed treatment programme that was of equal intensity
for both groups and tailored to individual needs. Treatment
goals and modalities were discussed during weekly multidis-
ciplinary team conferences. In addition, patients received
written information about how to handle their disease and
participated in a 1-hour educational session. Day care was
given from 10 a.m. to 4 p.m., with a fixed period of
1½ hours of bed rest. Inpatient and day patient care both
consisted of nine treatment days, given in a fixed period of
2 and 3 weeks, respectively.
Apart from the intervention period in the two team care
groups, the decision to change or introduce disease-modifying
drugs, optimize nonsteroidal anti-inflammatory drugs or
administer intra-articular steroid injections was left to the
rheumatologist at the outpatient clinic in all three study
groups.
Clinical assessments and outcome measures
All assessments at study entry and at 12, 52, and 104 weeks
of follow-up were carried out by two independent assessors
who were blinded to the patient’s treatment status. At
baseline, a medical doctor (GJT) made an inventory of the
medical history.
Clinical and socio-demographic characteristics recorded at
baseline were age, disease duration, sex, rheumatoid factor,
comorbidity (categorized as not present: Charlson index ¼ 0
and present: Charlson index of > 0) (Charlson et al. 1987),
living status [living alone or living with other person(s)] and
level of education (categorized as low: up to and including
lower technical and vocational training; medium: up to and
including secondary technical and vocational training; and
high: up to and including higher technical and vocational
training and university).
The independent assessors recorded the uptake of
(para)medical services and introduction of practical aids
and adaptations at weeks 26, 52, 78 and 104. Practical aids
and adaptations were categorized as follows: home adapta-
tions (heightened toilet or toilet seat, handles in the
bathroom, shower chair, adjusted taps, adjusted windows
and doors, alarm system, stair lift, adjusted kitchen, adjusted
doorsteps, orthopaedic shoe(s) (adaptation), walking aids
(stick, crutches, walking frame) and wheeled mobility aids
[tipping chair (electric) wheelchair, scooter, adjustment to
car]. Number of hospitalizations and use of home help and
nursing care at home were recorded by means of a question-
naire filled in by the patient.
Functional status
Functional status, the primary outcome measure, was meas-
ured with the health assessment questionnaire (HAQ) (Siegert
et al. 1984) and MacMaster Toronto Arthritis (MACTAR)
patient preference interview (Tugwell et al. 1987). The HAQ
contains 20 questions regarding eight domains of activities of
daily living. The final score ranges from 0 (no disability) to 3
(severe disability). In the MACTAR, an interviewer assesses
which activities are most impaired and most important
(maximum 5) to the individual patient, and follows changes
in these activities over time; it also includes questions on
social and emotional functioning. Recently, the MACTAR
has also been validated in Dutch patients (Verhoeven et al.
2000). Other (secondary) functional outcome measures
included grip strength (mean grip strength of right and left
hand) as measured by the Accoson vigorimeter meter and
walk test (time needed to walk a distance of 50 feet) (Grace
et al. 1988).
Quality of life
Quality of life was measured with the RAND 36-item
Health Survey 1Æ0 (RAND-36) (Hays et al. 1993) and
Rheumatoid Arthritis Quality of Life (RAQoL) question-
naire (Jong de et al. 1997). The RAND-36 contains sub-
scales for physical functioning, social functioning, role
limitations (physical problem), role limitations (emotional
problem), mental health, vitality, pain and general health
perception. Each sub-scale generates a score from 0 to 100,
with higher score indicating better health. The RAND-36
may be converted to two summary scales: physical and
mental component summary scales (Ware & Sherbourne
1992). The RAND-36 includes the same items as the
MOS-SF 36 and, although the scoring procedures are
somewhat different, the effects of these on the scores are
minimal (Hays et al. 1993). The RAQoL is a questionnaire
consisting of 30 items with a yes/no (1/0) response format.
It measures various areas of life, including moods and
emotions, social life, hobbies, everyday tasks, personal and
social relationships and physical contact. The overall score
is the sum of the individual item scores, with a lower score
indicating better quality of life. The RAND-36 and RAQoL
have been both validated for use in the Netherlands (Zee
van de & Sanderman 1993, Jong de et al. 1997, Tijhuis
et al. 2001).
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Disease activity
Disease activity was measured with the disease activity score
(DAS) (Prevoo et al. 1995). This is a composite index of
disease activity, including the number of tender joints, num-
ber of swollen joints, patient’s global assessment of disease
activity and erythrocyte sedimentation rate, according to the
following formula: 0Æ555 (tender joints) þ 0Æ284 (swollen
joints) þ 0Æ70 ln (erythrocyte sedimentation rate) þ 0Æ0142
(VAS patient’s global assessment of disease activity).
Data analysis
To test clinical equivalence, the largest acceptable clinical
difference in outcome between the groups was defined as 0Æ22
on the HAQ. A difference of > 0Æ22 has been found to be
clinically relevant (Redelmeier & Lorig 1993). Based on a
within-group standard deviation of 0Æ44, a total sample size
of 189 was required to detect this difference in the HAQ,
between the unpaired groups, with a power of 80% at the
P < 0Æ05 level (Student’s two tailed t-test). All analyses were
based on intention to treat as initially assigned. All available
data were used.
Measures with a Gaussian distribution are expressed as
means and SD; otherwise, medians and ranges are presented.
Patients’ characteristics and use of medical and paramedical
treatment during follow-up were compared using the
Kruskal–Wallis and Mann–Whitney U-test or Pearson Chi-
square test where appropriate. Within group differences in
clinical outcome between baseline and follow-up scores, and
between 12 and 52 weeks and 52 and 104 weeks were tested
with the Wilcoxon signed rank matched-pairs test. To
establish whether there were significant differences in clinical
outcomes between CNS patients, inpatients and day patients,
analysis of variance was performed on the change scores. In
this analysis, adjustments for statistically significant differ-
ences at baseline regarding clinically relevant variables (socio-
demographic and clinical variables and previous medical and
paramedical treatment) were made by entering the baseline
values of these variables as covariates into the analysis of
covariance. The analysis was repeated with both types of
team care (inpatient and day patient) taken together. Post hoc
analysis was performed with Bonferroni correction for
multiplicity.
Results
Analysis of the sample
Sixty of 270 patients who were screened for the study were
not randomized for the following reasons: did not fit entry
criteria (15), unwillingness to be randomized (10), private
circumstances (21) and the expectation that day care would
be too physically burdensome (14).
Thirty-one patients did not complete the study. They were
equally distributed over the three groups. Seven of these 31
patients died. Other reasons for withdrawal were: severe
comorbidity, deteriorating physical condition, unwillingness
and removal. A comparison of baseline parameters between
withdrawals and patients who completed 2-year follow-up
showed that withdrawals were significantly older, had longer
disease duration and more often had previous multidiscipli-
nary treatment, and a higher percentage had a positive
rheumatoid factor (P < 0Æ05).
During the initial treatment, one patient randomized to day
care was hospitalized because travelling was considered
physically too burdensome and one inpatient was hospital-
ized for 42 days instead of 9 days because of severity of RA
activity.
Table 1 Clinical and sociodemographic characteristics of 210 patients with rheumatoid arthritis and increasing difficulty in performing
activities of daily living
Characteristics Nurse specialist (n ¼ 71) Inpatient (n ¼ 71) Day patient (n ¼ 68)
Age, years; median (range) 54 (24–85)* 60 (22–80) 60 (29–82)
Disease duration, years; median (range) 2Æ1 (0–46) 2Æ1 (0Æ1–47) 1Æ4 (0–35)
Number of patients (%)
Women 51 (72) 53 (75) 54 (79)
With positive rheumatoid factor 44 (62) 52 (73) 47 (70)
With comorbidity 23 (32) 26 (37) 16 (24)
Living alone 10 (14) 17 (24) 15 (22)
With the following level of education
Low 33 (46) 44 (62) 35 (53)
Medium 28 (39) 20 (28) 24 (35)
High 10 (15) 7 (10) 8 (12)
*A significant difference between clinical nurse specialists’ patients and day patients and inpatients (Mann–Whitney U-test, P < 0Æ05).
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Clinical measures at baseline
At baseline, no differences were found between CNS patients,
inpatients and day patients with respect to clinical and socio-
economic characteristics, except that CNS patients were signi-
ficantly younger than day patients and inpatients (Table 1).
At baseline, CNS patients had significantly better scores on
the HAQ, RAND summary scales and RAQoL and higher
grip strength than inpatients and day patients (Table 2).
Furthermore, CNS ecialist patients had significantly lower
disease activity than day patients.
Table 2 Clinical outcome data at baseline [absolute values, means (SD)] and weeks 12, 52 and 104 [change scores from baseline, means (95%
confidence interval)] adjusted for age and differences at baseline
Baseline Week 12 Week 52 Week 104
HAQ (0–3)*
Nurse specialist patients 1Æ17 (0Æ65) 0Æ20 (0Æ07, 0Æ33)b 0Æ17 (0Æ03, 0Æ30)c 0Æ20 (0Æ06, 0Æ33)b
Inpatients 1Æ49 (0Æ71) 0Æ15 (0Æ02, 0Æ27)b 0Æ19 (0Æ06, 0Æ32)b 0Æ13 (0Æ03. 0Æ26)c
Day patients 1Æ54 (0Æ76) 0Æ34 (0Æ21, 0Æ47)a 0Æ36 (0Æ23, 0Æ50)a 0Æ35 (0Æ22, 0Æ48)a
MACTAR weighted
Nurse specialist patients 48Æ4 (3Æ7) 2Æ1 (4Æ7, 0Æ5) 4Æ3 (6Æ8, 1Æ8)b,§ 0Æ6 (3Æ3, 2Æ1)–
Inpatients 47Æ2 (3Æ6) 0Æ3 (2Æ9, 2Æ4) 0Æ6 (2Æ0, 3Æ1) 0Æ8 (2Æ0, 3Æ6)
Day patients 47Æ4 (3Æ7) 1Æ5 ( 4Æ2, 1Æ2) 5Æ3 (7Æ9, 2Æ6),a,§ 0Æ2 (3Æ0, 2Æ5)–
Grip strength* (0–300, mmHg)
Nurse specialist patients 190 (77) 17 (30, 5)c 23 (37, 9)b 18 (35, 2)
Inpatients 143 (64) 23 (35, 11)b 31 (44, 17)a 32 (48, 15)a
Day patients 155 (63 22 (34, 10)a 34 (48, 21)a 21 (37, 4)c,§
Walk test (seconds)
Nurse specialist patients 12Æ9 (6) 1Æ5 (0Æ7, 2Æ3)b 1Æ7 (0Æ7, 2Æ7)a 1Æ1 (0Æ1, 2Æ1)
Inpatients 13Æ5 (6) 1Æ0 (0Æ2, 1Æ8)c 1Æ2 (0Æ2, 2Æ2)c 0Æ1 (0Æ8, 1Æ1)§
Day patients 13Æ7 (7) 1Æ2 (0Æ4, 2Æ0)c 1Æ0 (0Æ0, 2Æ0) 1Æ2 (0Æ3, 2Æ2)c
RAND Physical summary scale (0–100)*
Nurse specialist patients 38Æ0 (21) 11Æ4 (16Æ9, 5Æ9)a 15Æ7 (21Æ5, 9Æ9)a 15Æ1 (21Æ0, 9Æ2)a
Inpatients 29Æ6 (17) 7Æ1 (12Æ5, 1Æ8)b 10Æ4 (16Æ0, 4Æ8)a 8Æ5 (14Æ3, 2Æ8)b
Day patients 28Æ2 (20) 15Æ6 (20Æ9, 10Æ2)a 15Æ7 (21Æ5, 9Æ9)a 11Æ2 (17Æ0, 5Æ4)a
RAND Mental summary scale (0–100)*
Nurse specialist patients 66Æ3 (24) 9Æ3 (14Æ7, 3Æ9) 8Æ6 (14Æ5, 2Æ7) 9Æ9 (16Æ1, 3Æ5)
Inpatients 53Æ0 (23) 4Æ8 (10Æ1, 0Æ5) 10Æ6 (16Æ2, 5Æ0)a 6Æ0 (12Æ1, 0Æ1)b
Day patients 51Æ3 (26) 7Æ1 (12Æ4, 1Æ8)b 9Æ3 (15Æ2, 3Æ3)b 7Æ3 (13Æ4, 1Æ2)b
RAQoL (0–30)*
Nurse specialist patients 13Æ8 (7) 1Æ0 (0Æ4, 2Æ4) 1Æ7 (0Æ3, 3Æ1)c 1Æ9 (0Æ5, 3Æ3)
Inpatients 17Æ0 (6) 1Æ2 (0Æ2, 2Æ6) 1Æ4 (0Æ1, 2Æ8)c 0Æ6 (0Æ8, 2Æ0)
Day patients 18Æ3 (7) 2Æ3 (0Æ9, 3Æ7)a 3Æ1 (1Æ6, 4Æ5)a 1Æ9 (0Æ5, 3Æ4)b
Disease activity score
Nurse specialist patients 5Æ32 (1Æ24) 0Æ7 (0Æ4, 0Æ9)a 1Æ3 (0Æ9, 1Æ6)a,– 1Æ1 (0Æ8, 1Æ5)a
Inpatients 5Æ72 (1Æ17) 0Æ4 (0Æ1, 0Æ7)b 0Æ9 (0Æ6, 1Æ2)a,§ 1Æ0 (0Æ6, 1Æ3)a
Day patients 5Æ85 (1Æ17) 0Æ7 (0Æ5, 1Æ0)a 1Æ2 (0Æ9, 1Æ5)a,– 0Æ9 (0Æ6, 1Æ3)a
Significant improvement between admission and week 12, 52, and/or 104 aP < 0Æ001, bP < 0Æ01, cP < 0Æ05 (Wilcoxon signed rank matched-
pairs test).
*Significant difference between clinical nurse specialists’ patients versus day patients and nurse specialist patients versus inpatients at baseline
(ANOVA, P < 0Æ01).
Significant difference between day patients versus inpatients (Mann–Whitney U-test, P < 0Æ01).
Significant difference between clinical nurse specialists’ patients versus day patients at baseline (Mann–Whitney U-test, P < 0Æ05).
§Significant difference(s) between weeks 12 and 52 and/or between weeks 52 and 104 (Wilcoxon signed rank matched-pairs test, P < 0Æ05).
–Significant difference(s) between weeks 12 and 52 and/or between weeks 52 and 104 (Wilcoxon signed rank matched-pairs test, P < 0Æ01).
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Medical treatment and use of health services during
the intervention period and 2-year follow-up
With respect to medical treatment in the first 12 weeks of
the study during which the interventions were completed in
all three study groups, CNS patients received significantly
fewer steroid injections in large joints than inpatients and
day patients in the first 6 weeks (P < 0Æ05) (Table 3). Over
the first 12 weeks (Table 3), as well as during 104 weeks
after the start of the study, no significant differences
between CNS patients, inpatients and day patients were
found with respect to the following treatment aspects:
change of second line therapy, change of anti-inflammatory
drug therapy, and oral use of prednisone (data not shown).
Between weeks 12–52 and 52–104, no significant differences
between CNS patients, inpatients and day patients were
found in the number of prescribed adaptive equipment and
house adaptations (Table 4), number of patients hospital-
ized, and numbers who had one or more contacts with a
physiotherapist, occupational therapist and/or social worker.
In the period between 12 and 52 and 52–104 weeks, visits
to a CNS were more frequent in the CNS group than in the
inpatient and day patient groups (P < 0Æ05) (Table 5).
Furthermore, in the period between 52 and 104 weeks more
inpatients than CNS patients group received home help
(P < 0Æ05) (Table 5).
Clinical measures during 2-year follow-up
During 2-year follow-up after the initial treatment all groups
improved in functional status, quality of life and disease
activity (Table 2). In general, no significant differences were
Weeks Nurse patients Inpatients Day patients P-value*
Starting with a new DMARD 6 12 22 18 0Æ167
12 5 5 1 0Æ229
Started with oral prednisone 6 3 3 2 0Æ886
12 0 0 3 0Æ051
Change of NSAID 6 12 15 14 0Æ844
12 12 9 8 0Æ589
Intra-articular steroid injections
One or more in small joints 6 3 2 4 0Æ684
12 2 1 0 0Æ363
One or more in large joints 6 6 16 17 0Æ032
12 11 9 6 0Æ449
*Chi-squared test.
Significant difference between nurse patients versus inpatient and day patients (Mann–Whitney
U-test).
Table 3 Medical treatment in clinical
nurse specialists’ patients, inpatients and
day patients during first 12 weeks
Number of patients with one or more Weeks
Nurse
patients Inpatients
Day
patients P-value*
Home adaptations 52 29 20 22 0Æ193
104 12 14 7 0Æ269
Orthopaedic shoes/shoe adaptations 52 27 22 27 0Æ489
104 11 15 7 0Æ203
Splint of wrist or knees 52 29 34 31 0Æ781
104 2 8 3 0Æ090
Walking aids 52 9 8 7 0Æ864
104 4 3 7 0Æ349
Wheeled mobility aids 52 5 6 3 0Æ609
104 3 3 3 0Æ999
*Chi-squared test.
Table 4 Introduction of practical aids and
adaptations in clinical nurse specialist’s
(CNSs) patients, inpatients and day patients
during 104 weeks follow-up, after the
intervention
G.J. Tijhuis et al.
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observed between the results obtained between weeks 12–52
and 52–104 in all three groups, except that between weeks 12
and 52 both CNS and day patients showed a further
significant improvement in functional status as measured
with the MACTAR, and in all three groups a significant
improvement in disease activity was seen. Furthermore,
between weeks 52 and 104 a significant deterioration was
found on the MACTAR and grip strength scores in day
patients, MACTAR scores in CNS patients, and walk test
scores in inpatients.
With respect to differences between the three groups, the
outcomes were very similar, except that day patients showed
significantly greater improvement in functional status as
measured with the MACTAR at week 52 (P < 0Æ01). A
statistical comparison of change scores in the CNS group
versus inpatient or day patient team care groups combined
did not reveal any significant differences in outcome.
Discussion
This study shows that over a period of 2 years care provided
by a CNS is equally as effective as inpatient and day patient
multidisciplinary team care. In general, the improvement
achieved by a short period of treatment remained stable over
a period of approximately 104 weeks follow-up after the
initial interventions.
The study had a randomized design and included two
investigators who were blinded to patients’ randomization
status. The effectiveness was evaluated by use of several
outcome measures commonly used in patients with RA, and
patients were followed during a period of 2 years, which is
much longer than in many other studies investigating these
types of care (Hill et al. 1994, Hill 1997, Vliet Vlieland &
Hazes 1997, Temmink et al. 2001).
All patients in the study had RA and increasing difficulty in
performing activities of daily living but were nevertheless able
to be randomized between the three types of multidisciplinary
care. Therefore, the results can be partly extrapolated to the
general population of RA patients and deteriorating func-
tional status, as for a number of these admission to hospital is
inevitable.
In this randomized trial, care provided by a CNS was
directly compared with multidisciplinary team care, which is
generally considered to be an optimal strategy for patients
with chronic diseases such as RA. The advantage of
co-ordinated health care delivered by a team over nonteam
care has been demonstrated in a systematic review on the role
of patient care teams in chronic disease management (Wagner
2000). Despite these results, the present study shows that
co-operation between a CNS and rheumatologist in
combination with care provided by other health professionals
results in an effective treatment regimen in which the clinical
Table 5 Numbers of patients with hospit-
alizations, receiving home help or using
paramedical services in nurse patients,
inpatients and day patients during
104 weeks follow-up, after the intervention
Number of patients Weeks Nurse patients Inpatients Day patients P-value*
Hospitalized 52 5 10 9 0Æ399
104 20 19 15 0Æ644
Receiving home help 52 9 21 17 0Æ058
104 10 23 17 0Æ029
Receiving nurse care at home 52 3 3 4 0Æ892
104 2 1 4 0Æ317
Number of patients having one
or more contacts with
Physiotherapist 52 41 46 40 0Æ795
104 35 38 31 0Æ681
Occupational therapist 52 8 7 5 0Æ699
104 2 4 2 0Æ642
Social worker 52 5 4 8 0Æ382
104 3 3 5 0Æ641
CNS 52 22 9 4 <0Æ001
104 12 5 4 0Æ045
*Chi-squared test.
Significant difference between nurse patients versus inpatients (chi-squared test, Mann–Whitney
U-test).
Significant difference between nurse patients versus inpatients and day patients (chi-squared
test, Mann–Whitney U-test).
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outcome does overall not differ from that of inpatient or day
patient team care.
Differences in role of the CNS, study design, outcome
measures and follow-up duration make comparison between
two earlier studies (Hill et al. 1994, Hill 1997, Temmink
et al. 2001) and the present study difficult. Patients who
received care by a CNS also improved in the study by Hill
et al. during a follow-up period of 48 and 104 weeks,
respectively. These results contrasts with those of Temmink’s
study, in which no effect was observed. Possible explanations
for differences in outcome may be the fact in Temmink’s
study not only RA patients were included, but more than
20% of the patients had other rheumatic diseases, and that
patients were selected on the presence of ‘problems regarding
their disease’, whereas in our study patients were included on
the basis of having ‘increasing functional limitations’ during
the last 6 weeks.
From several randomized trials it can be concluded that
inpatient team care has a beneficial effect in patients with
active RA in comparison with regular outpatient care (Lee
et al. 1974, Vliet Vlieland et al. 1996). Regarding the
comparison of inpatient team care with day patient team
care, the results of the present study are in line with those of a
previously published trial in which equivalent clinical out-
comes were reported (Lambert et al. 1998). In contrast with
that trial, the duration of the inpatient and day patient team
care in the present study were exactly the same, confirming
that staying overnight or for a weekend in hospital appears
not to have an additional value in multidisciplinary team
treatment. Furthermore, with regard to duration of benefit,
our present findings are in accordance with the results of an
earlier report by our group in which a positive effect of
inpatient care continued during 2-year follow-up (Vliet
Vlieland et al. 1997). This is in contrast with other
studies (Helewa et al. 1989, Lambert et al. 1998) and may
reflect differences in the intensity of regular outpatient
management.
The present study showed a sustained effect for most
outcome measures over the 2-year period after the start of the
initial treatment, except for the MACTAR. Probably this
questionnaire is less appropriate for measuring effectiveness
over such a long period because with this tool activities that
are most important to the individual patient at a certain time
are evaluated, and these specific activities may not be
considered that important or relevant after a longer period.
This study was performed with patients whose medical
condition was such that it was acceptable for them to be
randomized between all three types of care. Bearing this in
mind, factors that may eventually play a role in the choice of
treatment for patients with RA and functional limitations
may be the presence of complications and comorbidity,
availability of multidisciplinary facilities, patients’ and doc-
tors’ preferences, and financial considerations.
Finally, this study demonstrates that in the management
of patients with RA care provided by CNSs is a useful
addition to other multidisciplinary approaches which have
been available for a longer time, such as team care provided
in an inpatient or day care setting. With respect to the
process of innovation in complex disease management
various chronic diseases are no longer being considered in
isolation. It has been acknowledged that similar manage-
ment strategies can be applied in different chronic condi-
tions (Davis et al. 2000). Therefore, the results obtained
with patients with RA may be relevant to therapeutic
approaches to other chronic diseases, such as chronic
obstructive pulmonary diseases, diabetes, coronary artery
disease or neurological disorders. Management of these
chronic diseases also consists of complex multidisciplinary
treatment strategies which are nowadays more and more
executed in outpatient and day care settings and in which
CNSs are increasingly involved.
Conclusion
This study has demonstrated that in the management of
patients with RA, care provided by the CNSs in transmural
clinics is a useful addition to other multidisciplinary
approaches, which have been available for a longer time,
such as team care provided in an inpatient or day care
setting.
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